Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial - Wikidata - wikimedia - TriplyDB

Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial

Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial

http://www.wikidata.org/entity/Q28542588

about

Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?Impact of Molecular Diagnostics for Tuberculosis on Patient-Important Outcomes: A Systematic Review of Study Methodologies Data for action: collection and use of local data to end tuberculosis Second line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspective Microbiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment Initiation Impact on Patients' Treatment Outcomes of XpertMTB/RIF Implementation for the Diagnosis of Tuberculosis: Follow-Up of a Stepped-Wedge Randomized Clinical Trial Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda Tuberculosis innovations mean little if they cannot save lives Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert™ MTB/RIF era: a cohort study.Sputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda.Shortened first-line TB treatment in Brazil: potential cost savings for patients and health services.Comparing Tuberculosis Diagnostic Yield in Smear/Culture and Xpert® MTB/RIF-Based Algorithms Using a Non-Randomised Stepped-Wedge Design.Stepped wedge cluster randomised trials: a review of the statistical methodology used and available Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines.Xpert MTB/RIF - why the lack of morbidity and mortality impact in intervention trials?Implementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana's Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early antiretroviral therapy mortality.Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System.Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia.Mixed impact of Xpert(®) MTB/RIF on tuberculosis diagnosis in Cambodia An Evaluation of Passive and Active Approaches to Improve Tuberculosis Notifications in Afghanistan.Xpert MTB/RIF Assay Shows Faster Clearance of Mycobacterium tuberculosis DNA with Higher Levels of Rifapentine Exposure.Performance of a molecular assay to detect Mycobacterium tuberculosis complex DNA in clinical specimens: multicenter study in Brazil.Mycobacterium tuberculosis: 2014 Clinical trials in review The impact of the roll-out of rapid molecular diagnostic testing for tuberculosis on empirical treatment in Cape Town, South Africa Rolling Out Xpert® MTB/RIF for TB Detection in HIV-Infected Populations:An Opportunity for Systems Strengthening Proposed variations of the stepped-wedge design can be used to accommodate multiple interventions.Diagnosis of opportunistic infections: HIV co-infections - tuberculosis.Developments in Impact Assessment of New Diagnostic Algorithms for Tuberculosis Control.Understanding the incremental value of novel diagnostic tests for tuberculosis.Correction: Impact of Replacing Smear Microscopy with Xpert MTB/RIF for Diagnosing Tuberculosis in Brazil: A Stepped-Wedge Cluster-Randomized Trial.Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.[Budget impact of the incorporation of GeneXpert MTB/RIF for diagnosis of pulmonary tuberculosis from the perspective of the Brazilian Unified National Health System, Brazil, 2013-2017].Factors associated with tuberculosis treatment delay in patients co-infected with HIV in a high prevalence area in Brazil.Unsuccessful Xpert® MTB/RIF results: the Nigerian experience.Impact of introduction of Xpert MTB/RIF test on tuberculosis (TB) diagnosis in a city with high TB incidence in Brazil.Impact of involvement of non-formal health providers on TB case notification among migrant slum-dwelling populations in Odisha, India.A scoping review on the field validation and implementation of rapid diagnostic tests for vector-borne and other infectious diseases of poverty in urban areas

P2860

Q26740240-C42A26B6-C2A8-4DA0-AC9C-4BA844575133 Q26767271-2C19642E-EB7B-4657-973D-7DF5C7C32DD1 Q26777926-1DD0866A-71D3-4616-AEAE-4926751E6435 Q28074085-739BB6F1-B204-47F6-8663-5643773AEE5D Q28469353-C3C67E72-C808-4DED-AC02-655EC173BE1E Q28546736-6F05D1A0-5B42-450B-82D1-884341D69C51 Q28552438-7C7D592E-E932-4EDF-BDDB-4C79932BBE8F Q33627409-371FCECD-39D2-45D6-AA44-C179153E827F Q33808388-6C824D7F-3447-48A8-9FBA-232AE0F3B35A Q33884141-38034DF2-D56B-4E7D-89CF-6C94D3C9116D Q35901882-DB66395F-42CF-438E-B013-EED1B24C1C41 Q35941022-B48FE4F6-9E8F-4761-A548-44A9DCA1F2DF Q36042301-63F831CE-F43B-4B8B-86D0-F5C3B4E060DF Q36094215-5C9384B9-5F2E-494A-8A5F-98D788B58304 Q36136013-A873933A-7D22-4198-9B0C-339D1093672B Q36174697-822FD501-8F09-47D6-8129-1E66B35DC69C Q36489992-A60E71CD-5547-4793-B038-946FEB258076 Q36617071-8DB80595-A1B3-4624-AE2D-F24A6E8F8402 Q37020517-EAE7CAAE-CB5D-4F03-B454-14E4AAF2198E Q37309365-00824CCF-006F-4D4F-A9A1-0FFCDD8F90C3 Q37434341-9CE7F385-9EE5-47E7-ABD9-ABB444360A07 Q37626263-A3B8F616-D6F5-48D7-BFC5-142C82016075 Q38387116-B8DCAB6B-C454-401C-A4D6-1379C13341CF Q38399097-5C756D07-32A1-427E-AED3-0F77188454ED Q38645708-346F53CC-B630-40E0-BCDC-FE7C446B1542 Q38835512-378B3813-DBA9-4E4F-A7E3-79B30B1CAC26 Q39070206-D2426E85-277D-4ED2-A8C2-7E31D108CC43 Q39159921-48D58D69-1696-4C61-BBBB-1CC6A3398B75 Q40245352-BFDC3624-BC38-4B5C-B44C-BC524CAA7BA8 Q42682182-2C5A1B02-C257-494F-8C4A-C2BAE20C9B69 Q47121800-7688C395-109E-4D3E-9E53-5CBD3428BF38 Q50092985-EAE64507-BD25-490A-8338-A4EFE708A223 Q52602654-6D059E9C-D851-4F7F-A6CC-AB7446B7839D Q53698248-4289B4EE-DF8A-4DBC-9E7B-29CB64D6B872 Q55005895-2A14C643-D4EF-4E8C-9B5C-3CD6EEC8114B Q55024184-A1E3D9C5-8B66-40DD-867B-012E1C945C89 Q56669652-DCBFECE6-BD6E-4280-AE76-B22E5EF808F6

P2860

Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial

http://www.wikidata.org/entity/Q28542588

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Impact of replacing smear micr ...... wedge cluster-randomized trial

@ast

Impact of replacing smear micr ...... wedge cluster-randomized trial

@en

Impact of replacing smear micr ...... wedge cluster-randomized trial

@nl

type

label

Impact of replacing smear micr ...... wedge cluster-randomized trial

@ast

Impact of replacing smear micr ...... wedge cluster-randomized trial

@en

Impact of replacing smear micr ...... wedge cluster-randomized trial

@nl

prefLabel

Impact of replacing smear micr ...... wedge cluster-randomized trial

@ast

Impact of replacing smear micr ...... wedge cluster-randomized trial

@en

Impact of replacing smear micr ...... wedge cluster-randomized trial

@nl

P1433

Q28542588-A5AAE8A8-A47A-4E1D-9B30-300EE516D6DA

P1476

Q28542588-519C6151-947B-417D-94C7-B6106FA4DFF6

P2093

Q28542588-35E96358-5D1D-4A01-B42D-1BB5237385C5

Q28542588-588846DD-D513-4B81-9FBF-EE10723BE984

Q28542588-89F6247B-B676-49DA-B834-26C0D9B1DA98

Q28542588-9695E2D9-B672-427E-9CEE-300B7DC09467

Q28542588-CEE24751-5DC6-4009-AAF9-1E33D1050ACC

Q28542588-D488B193-43EB-4A09-9D57-4F9DDF0304A8

Q28542588-F23E9DD7-4F9C-48B2-9013-994381EDAEC9

P2860

Q28542588-09DDEC52-9D83-48DE-A176-60C9EE8CD3CC

Q28542588-0BAD9093-0AF7-497C-96E6-2510454F181E

Q28542588-0D5F956D-AADB-49E6-AD10-1F2E381C777F

Q28542588-16F3CC85-9CDE-4243-878B-6BFCE9219DFA

Q28542588-29072879-50D1-40E0-8D3E-339A06AACF8A

Q28542588-351179D7-9045-4DA1-9E5F-E6419AEF42BC

Q28542588-37C01042-282C-4737-AB2B-28D2BDA69DCD

Q28542588-3D7B1BE1-C0C0-402F-A686-956DFDF68CB8

Q28542588-4100C6C4-8F08-4E46-B9FD-8942C49CBC49

Q28542588-4AD1CB2D-65B0-48A0-AB1D-EE2068F65A1F

P304

Q28542588-159EF873-C0F0-4941-A634-C42CBAE7F13D

P31

Q28542588-3DBA92F7-0E71-4CB7-85C3-4C8F4306E47F

P3181

Q28542588-C262A091-0826-4BBB-BC44-0F3E38ABF0C6

P356

Q28542588-CCBC1B51-CF08-4E68-B5DE-ED5ECB4EA983

P407

Q28542588-FA22F074-3D31-4E38-AC73-600CAF5DF8A2

P433

Q28542588-50621BC2-AEF5-445D-9D64-11101A35C9C4

P478

Q28542588-F872930D-F5AE-4EBA-AFEC-3CB199D553CE

P50

Q28542588-57D6BB90-0AFB-42AB-A334-0123EB99C79C

P577

Q28542588-E2DAACBF-F11A-4FDA-85E1-EC4615C1F3A8

P5875

Q28542588-B3CC6DDE-9A5C-49B4-B434-E6611E130992

P698

Q28542588-B3378452-9894-4BE1-A979-5F4889CACE73

P921

Q28542588-2314A0E2-9C1B-4AA4-9C6B-249232AD51B0

Q28542588-32F5DEC4-5695-404B-9BF2-0DB4B13CCF50

P932

Q28542588-D533B7D9-008D-4453-B303-6414B11CC745

P3181

P356

JOURNAL.PMED.1001766

P1433

P1476

Impact of replacing smear micr ...... wedge cluster-randomized trial

@en

P2093

Alexandre Menezes

http://www.w3.org/2001/XMLSchema#string

Anete Trajman

http://www.w3.org/2001/XMLSchema#string

Betina Durovni

http://www.w3.org/2001/XMLSchema#string

Frank Cobelens

http://www.w3.org/2001/XMLSchema#string

Marcelo Cordeiro-Santos

http://www.w3.org/2001/XMLSchema#string

Solange Cavalcante

http://www.w3.org/2001/XMLSchema#string

Susan van den Hof

http://www.w3.org/2001/XMLSchema#string

P2860

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

Improving the reporting of pragmatic trials: an extension of the CONSORT statement

Studies with staggered starts: multiple baseline designs and group-randomized trials

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis

Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation

Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

Rapid molecular detection of tuberculosis and rifampin resistance

The stepped wedge trial design: a systematic review.

Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda.

P304

e1001766

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1009442

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PMED.1001766

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Valeria Saraceni

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269414805

http://www.w3.org/2001/XMLSchema#string

P698

25490549

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

4260794

http://www.w3.org/2001/XMLSchema#string